Wuhan Hiteck Biological
PUBLIC
STATUS
301-400
EMPLOYEES
300683
STOCK SYMBOL
$4.20
SHARE PRICE
(As of Wednesday Closing)
Description
Wuhan Hiteck Biological Pharma Co Ltd is a biopharmaceutical manufacturing enterprise in China. The company is primarily engaged in the development, production and sale of biological products. Its product portfolio comprises rat nerve growth factor freeze-dried powder injection, injection of anti-hepatitis B transfer factor freeze-dried powder injection, thrombin and other chemicals. The company also has more than 20 kinds of products such as hepatitis B treatment drug op Heparin and hemostatic agent thrombin.
Primary Industry
Drug Discovery
Stock Exchange
SHE
Primary Office
- Hite Science and Technology Park
- Wuhan Economic Development Zone
- Wuhan, Hubei 430056
- China
+86 027 0000 0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Wuhan Hiteck Biological’s full profile, request a free trial.
Wuhan Hiteck Biological Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $3.69 - $9.11 | $429M | $4.15 | $0.20 | 799K | 103M |
Wuhan Hiteck Biological Financials Summary
|
In Thousands,
USD |
TTM
30-Sep-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
FY 2015
31-Dec-2015
|
|---|---|---|---|---|
| Enterprise Value | 326,013 | 778,425 | ||
| Revenue | 89,500 | 111,019 | 115,747 | 108,190 |
| EBITDA | 19,479 | 24,612 | 27,684 | 16,285 |
| Net Income | 16,776 | 21,070 | 23,579 | 13,272 |
| Total Assets | 271,431 | 292,364 | 149,662 | 134,399 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Wuhan Hiteck Biological Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Wuhan Hiteck Biological‘s full profile, request access.
Request full access to PitchBook